肝硬化中的巨噬细胞标志物与固有免疫 - Suppr

Suppr

超能文献

Macrophage markers and innate immunity in cirrhosis.

作者信息

Grønbæk Henning, Gantzel Rasmus Hvidbjerg, Laursen Tea Lund, Kazankov Konstantin, Møller Holger Jon

机构信息

Department of Hepatology & Gastroenterology, Aarhus University Hospital, Aarhus, Denmark.

出版信息

J Hepatol. 2020 Dec;73(6):1586-1588. doi: 10.1016/j.jhep.2020.07.033. Epub 2020 Sep 29.

DOI:10.1016/j.jhep.2020.07.033

PMID:32994078

Abstract

摘要

相似文献

Macrophage markers and innate immunity in cirrhosis.肝硬化中的巨噬细胞标志物与固有免疫

J Hepatol. 2020 Dec;73(6):1586-1588. doi: 10.1016/j.jhep.2020.07.033. Epub 2020 Sep 29.

Macrophage activation markers predict mortality in patients with liver cirrhosis without or with acute-on-chronic liver failure (ACLF).巨噬细胞活化标志物可预测无或有慢加急性肝衰竭（ACLF）的肝硬化患者的死亡率。

J Hepatol. 2016 Apr;64(4):813-22. doi: 10.1016/j.jhep.2015.11.021. Epub 2015 Nov 27.

Macrophage activation marker, soluble CD163, is an independent predictor of short-term mortality in patients with cirrhosis and bacterial infection.巨噬细胞活化标志物可溶性 CD163 是肝硬化合并细菌感染患者短期死亡率的独立预测因子。

Liver Int. 2016 Nov;36(11):1628-1638. doi: 10.1111/liv.13133. Epub 2016 May 5.

Regulation of Monocyte-Macrophage Responses in Cirrhosis-Role of Innate Immune Programming and Checkpoint Receptors.肝硬化中单核细胞-巨噬细胞反应的调节-固有免疫编程和检查点受体的作用。

Front Immunol. 2019 Feb 5;10:167. doi: 10.3389/fimmu.2019.00167. eCollection 2019.

Macrophage Activation Markers, CD163 and CD206, in Acute-on-Chronic Liver Failure.慢性加急性肝衰竭中的巨噬细胞活化标志物 CD163 和 CD206。

Cells. 2020 May 9;9(5):1175. doi: 10.3390/cells9051175.

Activated Hepatic Stellate Cells Induce Infiltration and Formation of CD163 Macrophages CCL2/CCR2 Pathway.活化的肝星状细胞通过CCL2/CCR2途径诱导CD163巨噬细胞浸润和形成。

Front Med (Lausanne). 2021 Feb 5;8:627927. doi: 10.3389/fmed.2021.627927. eCollection 2021.

Expression of STING Is Increased in Liver Tissues From Patients With NAFLD and Promotes Macrophage-Mediated Hepatic Inflammation and Fibrosis in Mice.STING 在非酒精性脂肪性肝病患者的肝组织中表达增加，并促进小鼠巨噬细胞介导的肝炎症和纤维化。

Gastroenterology. 2018 Dec;155(6):1971-1984.e4. doi: 10.1053/j.gastro.2018.09.010. Epub 2018 Sep 10.

In Vivo siRNA Delivery to Immunosuppressive Liver Macrophages by α-Mannosyl-Functionalized Cationic Nanohydrogel Particles.α-甘露糖基化阳离子纳米水凝胶颗粒经体内递送至免疫抑制性肝巨噬细胞的 siRNA。

Cells. 2020 Aug 15;9(8):1905. doi: 10.3390/cells9081905.

Systematic Evaluation of the Cellular Innate Immune Response During the Process of Human Atherosclerosis.人类动脉粥样硬化过程中细胞固有免疫反应的系统评价

J Am Heart Assoc. 2016 Jun 16;5(6):e002860. doi: 10.1161/JAHA.115.002860.

Macrophage Activation Markers, Soluble CD163 and Mannose Receptor, in Liver Fibrosis.肝纤维化中的巨噬细胞活化标志物——可溶性CD163和甘露糖受体

Front Med (Lausanne). 2021 Jan 8;7:615599. doi: 10.3389/fmed.2020.615599. eCollection 2020.

引用本文的文献

Elevated Liver Enzymes in Turner Syndrome: The Role of Low-grade Inflammation and Hormonal Imbalances.特纳综合征中的肝酶升高：低度炎症和激素失衡的作用

J Endocr Soc. 2025 Apr 7;9(6):bvaf059. doi: 10.1210/jendso/bvaf059. eCollection 2025 Jun.

Single cell-spatial transcriptomics and bulk multi-omics analysis of heterogeneity and ecosystems in hepatocellular carcinoma.肝细胞癌异质性和生态系统的单细胞空间转录组学及批量多组学分析

NPJ Precis Oncol. 2024 Nov 15;8(1):262. doi: 10.1038/s41698-024-00752-1.

Macrophage activation markers are associated with infection and mortality in patients with acute liver failure.巨噬细胞活化标志物与急性肝衰竭患者的感染和死亡率相关。

Liver Int. 2024 Aug;44(8):1900-1911. doi: 10.1111/liv.15928. Epub 2024 Apr 8.

Plasticity of monocytes and macrophages in cirrhosis of the liver.肝硬化中单核细胞和巨噬细胞的可塑性

Front Netw Physiol. 2022 Jul 15;2:937739. doi: 10.3389/fnetp.2022.937739. eCollection 2022.

The Salivary Microbiota of Patients With Primary Biliary Cholangitis Is Distinctive and Pathogenic.原发性胆汁性胆管炎患者的唾液微生物群具有独特性且具致病性。

Front Immunol. 2021 Jul 21;12:713647. doi: 10.3389/fimmu.2021.713647. eCollection 2021.

Divergences in Macrophage Activation Markers Soluble CD163 and Mannose Receptor in Patients With Non-cirrhotic and Cirrhotic Portal Hypertension.非肝硬化和肝硬化门静脉高压患者巨噬细胞活化标志物可溶性CD163和甘露糖受体的差异

Front Physiol. 2021 Jun 11;12:649668. doi: 10.3389/fphys.2021.649668. eCollection 2021.

Macrophages in Chronic Liver Failure: Diversity, Plasticity and Therapeutic Targeting.慢性肝衰竭中的巨噬细胞：多样性、可塑性和治疗靶点。

Front Immunol. 2021 Apr 2;12:661182. doi: 10.3389/fimmu.2021.661182. eCollection 2021.

Macrophage Activation Markers, Soluble CD163 and Mannose Receptor, in Liver Fibrosis.肝纤维化中的巨噬细胞活化标志物——可溶性CD163和甘露糖受体

Front Med (Lausanne). 2021 Jan 8;7:615599. doi: 10.3389/fmed.2020.615599. eCollection 2020.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验